Jia Jie Biomedical Co Ltd (4109) — Free Cash Flow Generation Index

Latest as of December 2025: -1.51x

Jia Jie Biomedical Co Ltd (4109) has a Free Cash Flow Generation Index of -1.51x as of December 2025. Free cash flow of NT$-17.15 Million represents -2% of operating cash flow (NT$11.32 Million). Read 4109 total debt and obligations for a breakdown of total debt and financial obligations.

FCF Generation Index

-1.51x
Free Cash Flow / Operating CF

Free Cash Flow

NT$-17.15 Million
TWD

Operating Cash Flow

NT$11.32 Million
TWD

Capital Expenditures

NT$28.47 Million
TWD

Jia Jie Biomedical Co Ltd Free Cash Flow Generation Index (2015–2025)

Historical FCF Generation Index trend for Jia Jie Biomedical Co Ltd across 6 annual periods. Explore 4109 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Jia Jie Biomedical Co Ltd (2015–2025)

Year-by-year Free Cash Flow Generation Index for Jia Jie Biomedical Co Ltd. For the full company profile including market capitalisation, see 4109 market cap.

Year FCG Index Free Cash Flow (TWD) Operating CF Capital Expenditures YoY Change
2025 -3.01x NT$-64.15 Million NT$21.34 Million NT$85.50 Million ▼ -639.2%
2024 0.56x NT$24.72 Million NT$44.35 Million NT$19.63 Million ▼ -14.6%
2021 0.65x NT$2.85 Million NT$4.37 Million NT$1.52 Million ▼ -30.6%
2020 0.94x NT$25.47 Million NT$27.10 Million NT$1.63 Million ▲ +7.2%
2019 0.88x NT$21.66 Million NT$24.71 Million NT$3.05 Million ▼ -79.8%
2015 4.33x NT$356.07 Million NT$82.22 Million NT$273.85 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).